CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro
- PMID: 17956895
- DOI: 10.1093/hmg/ddm309
CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro
Abstract
The charged multivesicular body protein 2B gene (CHMP2B) was recently associated with frontotemporal lobar degeneration (FTLD) linked to chromosome 3 in a Danish FTLD family (FTD-3). In this family, a mutation in the acceptor splice site of exon 6 produced two aberrant transcripts predicting two C-truncated CHMP2B proteins due to a read through of intron 5 (p.Met178ValfsX2) and a cryptic splicing event within exon 6 (p.Met178LeufsX30). Extensive mutation analysis of CHMP2B in Belgian patients (N = 146) identified one nonsense mutation in exon 5 (c.493C>T) in a familial FTLD patient, predicting a C-truncated protein p.Gln165X analogous to the Danish mutant proteins. Overexpression of Belgian p.Gln165X in human neuroblastoma SK-N-SH cells showed the formation of large, aberrant endosomal structures that were highly similar to those observed for Danish p.Met178ValfsX2. Together, these data suggest that C-truncating mutations in CHMP2B might underlie the pathogenic mechanism in FTLD by disturbing endosome function. We also describe a missense mutation in exon 5 of CHMP2B (p.Asn143Ser) in a familial patient with cortical basal degeneration. However, the pathogenic character of this mutation remains elusive.
Similar articles
-
CHMP2B mutations are not a common cause of frontotemporal lobar degeneration.Neurosci Lett. 2006 May 1;398(1-2):83-4. doi: 10.1016/j.neulet.2005.12.056. Epub 2006 Jan 23. Neurosci Lett. 2006. PMID: 16431024
-
CHMP2B mutations are rare in French families with frontotemporal lobar degeneration.J Neurol. 2010 Dec;257(12):2032-6. doi: 10.1007/s00415-010-5655-8. Epub 2010 Jul 14. J Neurol. 2010. PMID: 20625756
-
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.Nat Genet. 2005 Aug;37(8):806-8. doi: 10.1038/ng1609. Epub 2005 Jul 24. Nat Genet. 2005. PMID: 16041373
-
A novel splice-site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review.Mol Genet Genomic Med. 2023 Aug;11(8):e2222. doi: 10.1002/mgg3.2222. Epub 2023 Jun 5. Mol Genet Genomic Med. 2023. PMID: 37272767 Free PMC article. Review.
-
The role of CHMP2B in frontotemporal dementia.Biochem Soc Trans. 2009 Feb;37(Pt 1):208-12. doi: 10.1042/BST0370208. Biochem Soc Trans. 2009. PMID: 19143633 Review.
Cited by
-
The genetics and neuropathology of frontotemporal lobar degeneration.Acta Neuropathol. 2012 Sep;124(3):353-72. doi: 10.1007/s00401-012-1029-x. Epub 2012 Aug 14. Acta Neuropathol. 2012. PMID: 22890575 Free PMC article. Review.
-
Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.Prog Neurobiol. 2011 Mar;93(3):313-40. doi: 10.1016/j.pneurobio.2011.01.003. Epub 2011 Jan 7. Prog Neurobiol. 2011. PMID: 21216273 Free PMC article. Review.
-
Expression of mutant CHMP2B linked to neurodegeneration in humans disrupts circadian rhythms in Drosophila.FASEB Bioadv. 2019 Jul 11;1(8):511-520. doi: 10.1096/fba.2019-00042. eCollection 2019 Aug. FASEB Bioadv. 2019. PMID: 32123847 Free PMC article.
-
Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.Neuron. 2017 Oct 11;96(2):285-297. doi: 10.1016/j.neuron.2017.07.029. Neuron. 2017. PMID: 29024655 Free PMC article. Review.
-
Neuroprotective activity of ursodeoxycholic acid in CHMP2BIntron5 models of frontotemporal dementia.Neurobiol Dis. 2020 Oct;144:105047. doi: 10.1016/j.nbd.2020.105047. Epub 2020 Aug 13. Neurobiol Dis. 2020. PMID: 32801000 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical